Pea Protein Market Size & Share 2026-2035

Pea Protein Market Size

The global pea protein market was valued at USD 731.1 million in 2025 and is projected to reach USD 1.7 billion by 2035, expanding at a CAGR of 8.52% from 2026 to 2035.

Growth follows a strong 2022–2024 expansion phase, when market value rose from USD 520.35 million to USD 652.73 million, but the forecast reflects a more disciplined market than the earlier plant-based-food surge. Demand is moving toward applications where pea protein solves a defined formulation problem: high protein density in dairy-free beverages, texture in meat alternatives, allergen-conscious nutrition, and plant-derived functional ingredients.

Processing technology determines both product economics and end-use suitability. Wet fractionation produces isolates with approximately 80–90% protein, supporting high-protein beverage, clinical nutrition, and performance-nutrition uses. Dry fractionation produces concentrates with lower protein concentration but retains more native fiber and uses materially less energy and water. A 2024 assessment found that dry fractionation can reduce global-warming potential by up to 93% per kilogram of protein recovered relative to conventional wet processing.^{[1]Leich et al. - Techno-eco-environmental assessment of dry fractionation of protein concentrates from yellow peas with different pre-treatment methods, 2024 - doi.org} This creates a practical choice for buyers: isolates provide formulation precision, whereas concentrates can support protein-and-fiber positioning with a lower processing burden.

Pea protein's food-formulation appeal also rests on its position outside the major-allergen lists used in the United States and Canada, although this does not eliminate the risk of individual sensitivity or legume cross-reactivity. The U.S. Food and Drug Administration does not identify pea among the major food allergens subject to mandatory declaration under the Food Allergen Labeling and Consumer Protection Act .^{[2]U.S. Food and Drug Administration - GRAS Notice Summary: Pea Protein Concentrate (GRN No. 000851), 2019 - fda.gov} Canadian guidance similarly notes that pea is not a priority allergen, while cautioning that people with peanut allergy may react to pea protein in some circumstances. For manufacturers, that distinction makes pea protein a useful alternative where soy, dairy, or gluten avoidance is central to product architecture, but it does not remove the need for transparent ingredient communication.

Supply conditions remain closely tied to Canadian yellow-pea availability. Western Canadian pea production reached 3.0 million metric tons in 2024, up 14.9% from 2023, with Saskatchewan accounting for 51.3% of output, Alberta 39.9%, and Manitoba 8.8%. China remains an important destination for imported peas and a major processor, making trade flows relevant to both feedstock pricing and finished-protein competition. In the United States, trade remedies have materially changed the economics of Chinese-origin pea protein: final antidumping and countervailing-duty orders took effect in August 2024. Canada also initiated dumping and subsidy investigations into high-protein-content pea protein from China in April 2024.

Processing investment signals a shift from dependence on imported finished ingredients toward more regionalized capacity. Louis Dreyfus Company began construction of a pea protein isolate facility in Yorkton, Saskatchewan, in June 2024, with operations targeted by the end of 2025. In Europe, Ingredion and Lantmännen announced a long-term partnership in November 2024 under which Lantmännen plans to invest more than €100 million in a Swedish yellow pea protein isolate facility scheduled for completion in 2027. The commercial importance of these projects is not simply added capacity: nearby processing can improve raw-material traceability, reduce exposure to cross-border disruptions, and give food manufacturers alternatives when trade measures reshape delivered costs.

Demand diversification is equally important. Meat substitutes remain the largest outlet, but beverage-ready isolates, hydrolysates, textured proteins, and personal-care ingredients reduce reliance on a single category whose consumer demand can be volatile. The most durable growth opportunities are likely to favor processors that translate pea protein's allergen-positioning, processing footprint, and functionality into products with measurable formulation value rather than relying on generic plant-based claims.

This analysis covers the global pea protein market across the 2022–2024 historical period, with 2025 as the base year and 2026–2035 as the forecast period. Market values are expressed in USD million.

Key Drivers

Health-oriented and allergen-conscious protein formulation

Pea protein benefits from the overlap between plant-forward eating, dairy avoidance, gluten-free formulation, and demand for recognizable ingredient lists. Unlike a generic protein fortifier, it can address several formulation constraints simultaneously: it supplies protein, supports vegan claims, avoids dairy, and can be sourced from non-GMO supply chains. This is particularly relevant for brands developing products for consumers who alternate between animal and plant proteins rather than follow exclusively vegetarian diets.

Packaged-food activity indicates that pea protein is becoming more embedded in mainstream formulations. Agriculture and Agri-Food Canada recorded 25,171 metric tons of pea protein in U.S. packaged-food products in 2023 and projected 28,651 metric tons by 2027.^{[3]Agriculture and Agri-Food Canada - Pea Protein Isolate as an Ingredient in Packaged Food and Beverage: Product Launch Analysis - agriculture.canada.ca} The implication is not that all product launches will generate sustained volume, but that pea protein is increasingly being incorporated across multiple product formats, widening the demand base beyond plant-based meat.

Clinical and functional-nutrition demand

The market's nutraceutical and healthy-aging potential is supported by broader evidence on plant proteins and cardiometabolic outcomes. A systematic review and meta-analysis of randomized controlled trials found that replacing animal protein with plant protein was associated with reductions in LDL cholesterol and non-HDL cholesterol.^{[4]Jenkins et al. - Effect of Plant Protein on Blood Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, 2017 - ahajournals.org} Pea protein should not be treated as interchangeable with all plant proteins in claim substantiation, but this evidence strengthens the rationale for formulations aimed at heart-health, satiety, and protein adequacy.

Research on pulse proteins and hydrolysates has identified mechanisms relevant to functional-food development, including angiotensin-converting-enzyme inhibition and carbohydrate-digestive-enzyme inhibition. For ingredient suppliers, the commercial opportunity lies in delivering protein ingredients with sufficient sensory quality, solubility, and documentation for finished-product developers to build credible nutrition positioning. Hydrolysis can be particularly useful where lower viscosity or improved digestibility is more valuable than intact-protein functionality.

Application-specific innovation in foods and beverages

The next stage of market expansion depends on reducing longstanding sensory and processing barriers. Roquette expanded its NUTRALYS® range in February 2024 with an isolate for gelled food systems, a pea hydrolysate for lower-viscosity applications, and textured formats for minced and chunk-style meat alternatives. These launches reflect a shift away from one-size-fits-all pea protein toward ingredients engineered for specific sensory and processing outcomes.

Ingredion introduced VITESSENCE® Pea 100 HD for cold-pressed bars in July 2024 and VITESSENCE® Pea 200 D for nutritional beverages in October 2024. Axiom Foods also reported that production of its acid-stable Vegotein™ CLEAR pea protein doubled year over year in 2024 as transparent beverage applications gained traction. Such products address the practical obstacles that have limited adoption in beverages and bars: grittiness, off-notes, poor dispersibility, opacity, and texture hardening over shelf life.

Key Restraints

Feedstock and processing-cost volatility

Yellow peas are agricultural inputs, so weather conditions, crop quality, freight, and import policy can all affect delivered protein costs. Canadian output increased in 2024, but production remained below the 10-year average, illustrating the degree to which Prairie weather can influence availability even in a major producing region. Processors using wet fractionation are especially exposed because high fixed costs combine with feedstock-price risk; a decline in demand or a spike in pea costs can rapidly pressure plant utilization and margins.

Trade remedies may restore a degree of pricing discipline in the United States, but they can also tighten the range of immediately available supply options. The U.S. Department of Commerce's final determinations impose antidumping rates ranging from 122.19% to 280.31% and countervailing-duty rates ranging from 15.15% to 355.89% on certain pea protein from China. Buyers that had relied on Chinese supply must now weigh the benefits of alternative regional sourcing against potentially higher procurement costs.

Allergen sensitivity and workplace exposure

Pea is not a major allergen under current U.S. or Canadian labeling rules, yet clinical literature has documented pea allergy and potential cross-reactivity among legumes. A U.S. pediatric case series identified pea protein as a hidden allergen in processed foods, particularly because its presence may not be anticipated by consumers managing legume allergies. This is a manageable but meaningful risk for product developers using pea protein in categories where consumers expect transparent allergen communication.

Regulatory scrutiny is more material in Europe. A Belgian scientific assessment concluded that pea and other emerging plant proteins should be evaluated for possible inclusion in the European Union's allergen framework. Occupational exposure also requires attention: a 2024 case report documented IgE-mediated occupational asthma associated with pea flour exposure in bakery work. Ingredient manufacturers and food processors can mitigate these risks through dust-control systems, clear product specifications, and appropriate labeling practices, but these measures add compliance and operational complexity.

Allergen risk is more likely to influence product design and regulatory monitoring than to halt category growth. Its significance varies by application: a branded sports powder can communicate ingredients directly to a buyer, while a widely distributed bakery or prepared-food product creates more complex exposure and labeling considerations. Suppliers that provide validated allergen-management documentation and low-dust handling guidance can convert a regulatory concern into a service advantage.

Pea Protein Market Segment Analysis

By Product

Isolates generated USD 327.29 million in 2025, representing 44.8% of market value, and are projected to reach USD 752.04 million by 2035. Their high protein concentration makes them appropriate for nutritional beverages, powdered supplements, and clinical formats where protein density matters more than ingredient cost. However, isolates face the most exacting sensory expectations because they frequently compete with whey and dairy proteins in beverages and bars. Suppliers that improve dispersibility and flavor neutrality can extend isolate use into formats that historically favored dairy proteins.

Concentrates accounted for USD 254.18 million in 2025 and are expected to reach USD 581.12 million by 2035. Their lower-cost dry-fractionation route and retained fiber support use in bakery, snacks, pasta, and other applications where a dual protein-and-fiber proposition can be commercially useful. AGT offers pea protein concentrate with at least 55% protein, alongside isolate and textured pea protein formats for food manufacturing.^{[5]AGT Food and Ingredients - Pulse Ingredients Product Catalog, 2025 - agtfoods.com} Concentrates are less suited to applications requiring very high protein concentration, but their economics and sustainability profile make them relevant where nutrition density is balanced against cost and processing efficiency.

Textured pea protein represented USD 149.59 million, or 20.5% of market value, in 2025 and is projected to reach USD 376.02 million by 2035. This segment depends on extrusion technology to create structures that carry the chew, firmness, and moisture behavior expected in meat alternatives. Its demand is therefore tied less to broad protein consumption than to whether finished plant-based products can meet consumer expectations for taste, texture, and value. Product formats such as Roquette's minced and fibrous textured proteins illustrate how texture is being tailored to individual meal occasions rather than treated as a single commodity input.^{[6]Roquette - Extension of NUTRALYS® Plant Protein Range, February 21, 2024 - roquette.com}

By Application

Meat substitutes remained the largest application segment at USD 295.80 million in 2025, or 40.5% of market value, and are forecast to reach USD 717.85 million by 2035. The application requires both high-protein isolates for binding and nutrition claims and textured proteins for structural performance. Its growth depends on improving the sensory and cost parity of finished products, which makes ingredient functionality commercially consequential rather than merely technical.

Nutraceuticals accounted for USD 181.08 million in 2025 and are projected to reach USD 410.20 million by 2035. This segment can draw on the broader body of evidence around plant proteins, but product developers must avoid extending general health findings into unsupported pea-specific claims. The strongest opportunity is in formulations where protein adequacy, satiety, dairy avoidance, and functional nutrition overlap, particularly for healthy aging and lifestyle-oriented supplement users.

Sport supplements generated USD 147.90 million in 2025 and are projected to reach USD 358.93 million by 2035. Clear, acid-stable proteins and neutral-tasting dispersible isolates widen pea protein's addressable market from powder tubs into ready-to-drink and hydration-adjacent formats. The category remains highly sensitive to taste, texture, and price, so technical advances that reduce formulation compromises can have a disproportionate effect on repeat purchase and brand adoption.

The other-applications segment, including bakery fortification, dairy alternatives, pet food, and personal care, totaled USD 106.28 million in 2025 and is expected to reach USD 222.19 million by 2035. Hydrolyzed pea peptides offer an emerging premium pathway in beauty formulations. PURIS supplies pea-derived ingredients for hair-care and skin-care applications, while Sensient Beauty positions Sensibiopro® Pea Protein for hair-conditioning performance. These applications are smaller than food uses but can improve product-mix value for suppliers with hydrolysis and specialty-formulation capabilities.

By Form

Dry pea protein dominated the market with USD 618.03 million in 2025, representing 84.5% share, and is forecast to reach USD 1,418.61 million by 2035. Powder and granule formats fit established global ingredient logistics, offer ambient stability, and are compatible with blending, extrusion, and dry-mix manufacturing. Their dominance reflects supply-chain practicality as much as end-user preference.

Liquid pea protein reached USD 113.03 million in 2025 and is projected to reach USD 290.56 million by 2035. Liquid formats can reduce handling steps in continuous beverage and dairy-alternative processing, but their value depends on managing viscosity, microbiological stability, and transport economics. The European Commission has determined that high-purity pea protein described in a consultation is not novel under Regulation (EU) 2015/2283, supporting its established use history in relevant applications.

By Distribution Channel

Supermarkets and hypermarkets led distribution with USD 252.50 million in 2025 and are projected to reach USD 564.03 million by 2035. They are important for finished foods containing pea protein, including meat alternatives, dairy alternatives, and protein-fortified snacks. Their role is closely connected to mainstream shelf placement and the ability of finished-product brands to sustain consumer trial.

Online/e-commerce channels accounted for USD 222.69 million in 2025 and are forecast to reach USD 546.94 million by 2035. Digital channels are particularly relevant to sports nutrition and nutraceutical products, where consumers compare ingredients, certifications, flavors, and serving formats before purchase. This environment can favor differentiated pea-protein products, but it also raises price transparency and intensifies competition among brands.

Pharmacies and drugstores represented USD 147.90 million in 2025, while other channels accounted for USD 107.97 million. Pharmacy distribution is relevant where pea protein is sold within a nutrition, meal-replacement, or supplement context. Other channels include specialty retailers, foodservice, and direct business-to-business ingredient sales, the latter remaining the operational foundation for processors supplying food manufacturers.

The most consequential growth is likely to come from applications that reduce dependency on plant-based meat alone. Nutraceuticals, sports nutrition, beverage systems, and personal care each reward different technical attributes, from protein purity and clear solubility to hydrolysis and sensory control. A supplier's competitive position will increasingly depend on matching the right process route to the right application rather than attempting to use a standard pea isolate across all end markets.

Pea Protein Market Regional Analysis

North America

North America was the largest regional market at USD 232.42 million in 2025 and is forecast to reach USD 531.55 million by 2035, growing at an 8.28% CAGR. The U.S. market accounted for USD 191.75 million in 2025 and is projected to reach USD 438.53 million by 2035. The region combines large consumer markets for plant-based and performance nutrition with proximity to Canadian yellow-pea production, creating a supply-demand configuration not replicated elsewhere.

Canadian feedstock supports a substantial North American processing base. ADM supplies pea protein from its Enderlin, North Dakota operation ,^{[7]ADM - Pea Protein Nutrition Solutions - adm.com} while Cargill's investment in PURIS supported expansion of PURIS's Dawson, Minnesota production capacity.^{[8]Cargill - Cargill Invests Additional $75 Million to Propel PURIS Pea Protein Production, August 28, 2019 - prnewswire.com} The construction of the Yorkton facility adds further processing capability close to Saskatchewan pea production. The U.S. duties on Chinese pea protein are likely to reinforce the strategic value of this regional capacity, although processors will remain exposed to Canadian crop quality, freight, and competing export demand.

Europe

Europe generated USD 203.01 million in 2025 and is forecast to reach USD 461.48 million by 2035, at an 8.22% CAGR. The region is characterized by strong demand for clean-label food ingredients, established specialty-food manufacturing, and an increasingly localized processing strategy. Regulatory pathways also influence product innovation. Commission Implementing Regulation (EU) 2023/6 authorized pea and rice protein fermented by Lentinula edodes mycelia as a novel food in January 2023, demonstrating that advanced pea-protein derivatives can progress through a defined authorization route.

The Ingredion–Lantmännen partnership is strategically significant because it adds prospective Swedish isolate capacity rather than merely distributing imported ingredients. ADM and Marel also established an alternative-protein innovation center at Wageningen Campus in the Netherlands to accelerate development and commercialization of alternative protein solutions. Together, these initiatives support a European market in which sustainability, traceability, and application development can be as important as headline protein content.

Asia Pacific

Asia Pacific represented USD 181.08 million in 2025 and is expected to reach USD 410.20 million by 2035, expanding at an 8.18% CAGR. China's role is distinctive because it combines large-scale pea imports, domestic processing, and export-oriented competition in finished pea protein. This structure makes the region influential in global price formation even where local consumption is growing.

The region's opportunity extends beyond China. Demand for dairy-free nutrition, functional beverages, and performance supplements is expanding across urban consumer markets, but premium applications often require consistent sensory quality and protein functionality. Suppliers entering these markets must account for local price sensitivity, import dependence for high-grade ingredients, and the need to tailor flavor and format to local consumption habits.

Latin America

Latin America accounted for USD 67.48 million in 2025 and is projected to reach USD 170.92 million by 2035, achieving a 9.39% CAGR. Brazil and Mexico offer the most visible opportunities through sports nutrition, functional foods, and expanding demand for plant-forward products. The region's faster growth rate reflects a smaller initial base rather than a fully developed local processing ecosystem.

Import reliance creates both an opportunity and a constraint. North American and European suppliers can serve the region with established pea protein formats, but exchange-rate volatility and freight costs can quickly alter affordability for local manufacturers. Products that provide multifunctional value, such as concentrate-based protein-and-fiber formulations, may be better positioned than premium isolates where cost sensitivity is acute.

Middle East & Africa

Middle East & Africa was valued at USD 47.07 million in 2025 and is expected to reach USD 135.02 million by 2035, the highest regional CAGR at 10.74%. GCC markets are likely to provide the most immediate opportunities because of established health-retail systems, demand for sports nutrition, and a growing market for dietary supplements.

Halal certification, product traceability, and temperature-resilient distribution are operationally important in the region. Pea protein's plant origin can simplify product positioning, but finished products still require market-specific certification and labeling. Growth is likely to be concentrated in urban supplement, functional-beverage, and premium health-food channels before spreading more broadly into mass-market food applications.

The faster projected growth in Latin America and Middle East & Africa reflects demand development from smaller bases rather than a near-term shift in production leadership. These regions will remain import-dependent in the forecast period, making local purchasing power, exchange rates, certification requirements, and distributor capability central to commercial success. Asia Pacific will remain the most complex competitive region because it is simultaneously a source of demand, feedstock imports, processing capacity, and global pricing pressure.

Pea Protein Market Share & Competitive Landscape

The market is moderately concentrated. Roquette Freres held a 12.3% market share in 2025, followed by PURIS at 10.4%, ADM at 9.5%, Cargill at 8.7%, and Ingredion Incorporated at 7.8%. Together, these five companies accounted for 48.7% of market value. Their positions are supported by different capabilities: Roquette and PURIS combine scale with pea-protein specialization; ADM, Cargill, Kerry Group, and Ingredion bring wider ingredient portfolios and customer access; and technology-focused participants compete through processing, sensory, or application innovation.

Roquette's scale in pea processing and its NUTRALYS® product development program make it a central competitor in isolates, textured proteins, and hydrolysates. Its Portage la Prairie facility was launched as the world's largest pea protein plant, and Protein Industries Canada announced a 2024 project involving Roquette to improve Canadian plant-based ingredient and co-product capability.^{[9]Protein Industries Canada - Improving Canadian Plant-Based Ingredients, Food and Co-Products, May 7, 2024 - globenewswire.com} PURIS combines vertically integrated pea-protein operations with a strategic relationship with Cargill and has an important role in the post-duty U.S. supply environment.

Ingredion's 2024 launches demonstrate that competition is increasingly based on application performance rather than protein percentage alone. Axiom Foods is similarly focused on clear, acid-stable pea proteins for beverages. These offerings address a premium segment where processors can compete on formulation outcomes, including clarity, dispersibility, flavor, and shelf-life texture.

AGT Food and Ingredients participates across concentrates, isolates, textured proteins, flour, fiber, and starch, enabling customers to source several pulse-derived ingredients from one supplier. The Scoular Company supplies pea protein for food, beverage, and pet-nutrition applications, illustrating the importance of ingredient distribution and customer service alongside primary processing. Kerry Group's broader taste-and-nutrition capabilities position it to integrate plant proteins with flavor and texture solutions for food and beverage developers.

Other authorized participants include A&B Ingredients, Burcon NutraScience Corporation, Farbest Tallman Foods Corporation, Sotexpro, Glanbia Plc, and Emsland Group. Burcon's commercialization strategy has been shaped by the receivership of its former partner Merit Functional Foods; Burcon's fiscal 2024 disclosures identify its continued focus on plant-protein technology and commercialization options. Across this diverse company group, competitive advantage increasingly depends on access to reliable pea supply, the ability to manage sensory limitations, and the capability to support customers through product formulation and regulatory documentation.

Recent Industry Developments

U.S. antidumping and countervailing-duty orders, August 2024. The U.S. Department of Commerce issued final antidumping and countervailing-duty determinations on certain pea protein from China, with antidumping rates ranging from 122.19% to 280.31% and countervailing-duty rates ranging from 15.15% to 355.89%.

Canadian investigation initiation, April 2024. The Canada Border Services Agency initiated dumping and subsidizing investigations into high-protein-content pea protein from China following a complaint by Roquette Canada Limited and Nutri-Pea GP Inc.

Roquette NUTRALYS® range expansion, February 2024. Roquette launched new pea-protein products spanning high-gel-strength isolate, hydrolysate, and textured formats for meat-alternative, bar, beverage, and prepared-food applications.

Louis Dreyfus Company Yorkton facility construction, June 2024. Saskatchewan announced the start of construction on Louis Dreyfus Company's Yorkton pea protein production plant, with operation targeted by the end of 2025.

Ingredion–Lantmännen partnership, November 2024. Ingredion and Lantmännen announced a partnership supporting investment of more than €100 million in a Swedish yellow pea protein isolate facility planned for completion in 2027.

Ingredion product launches, 2024. Ingredion introduced VITESSENCE® Pea 100 HD for cold-pressed bars in July and VITESSENCE® Pea 200 D for nutritional beverages in October.

Axiom Foods production expansion, October 2024. Axiom Foods reported year-over-year production doubling for Vegotein™ CLEAR pea protein, citing demand for soluble proteins in acidic beverage applications.

EU novel-food authorization, January 2023. Commission Implementing Regulation (EU) 2023/6 authorized pea and rice protein fermented by Lentinula edodes mycelia as a novel food.